nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromocriptine—ABCB1—melanoma	0.163	1	CbGaD
Bromocriptine—CYP1A2—Carmustine—melanoma	0.0718	0.227	CbGbCtD
Bromocriptine—CYP1A2—Vemurafenib—melanoma	0.0568	0.179	CbGbCtD
Bromocriptine—CYP3A4—Temozolomide—melanoma	0.0543	0.172	CbGbCtD
Bromocriptine—CYP1A2—Dacarbazine—melanoma	0.0435	0.138	CbGbCtD
Bromocriptine—Cerebrospinal fluid leakage—Carmustine—melanoma	0.0349	0.158	CcSEcCtD
Bromocriptine—Neoplasm recurrence—Carmustine—melanoma	0.0349	0.158	CcSEcCtD
Bromocriptine—ABCB1—Dactinomycin—melanoma	0.033	0.104	CbGbCtD
Bromocriptine—CYP3A4—Vemurafenib—melanoma	0.0297	0.094	CbGbCtD
Bromocriptine—HTR1D—meninx—melanoma	0.0193	0.257	CbGeAlD
Bromocriptine—DRD5—eyelid—melanoma	0.0174	0.233	CbGeAlD
Bromocriptine—ABCB1—Docetaxel—melanoma	0.017	0.0538	CbGbCtD
Bromocriptine—CYP3A4—Docetaxel—melanoma	0.0102	0.0323	CbGbCtD
Bromocriptine—Status epilepticus—Temozolomide—melanoma	0.00495	0.0224	CcSEcCtD
Bromocriptine—Fibrosis—Carmustine—melanoma	0.00423	0.0191	CcSEcCtD
Bromocriptine—Vasospasm—Carmustine—melanoma	0.00354	0.016	CcSEcCtD
Bromocriptine—Pulmonary fibrosis—Bleomycin—melanoma	0.00315	0.0142	CcSEcCtD
Bromocriptine—Lung infiltration—Bleomycin—melanoma	0.00295	0.0134	CcSEcCtD
Bromocriptine—Pulmonary fibrosis—Carmustine—melanoma	0.00275	0.0124	CcSEcCtD
Bromocriptine—Pulmonary fibrosis—Temozolomide—melanoma	0.00265	0.012	CcSEcCtD
Bromocriptine—Lung infiltration—Carmustine—melanoma	0.00258	0.0117	CcSEcCtD
Bromocriptine—Vasculitis—Vemurafenib—melanoma	0.00234	0.0106	CcSEcCtD
Bromocriptine—HTR2A—hindlimb—melanoma	0.00228	0.0304	CbGeAlD
Bromocriptine—HTR1B—blood vessel—melanoma	0.00226	0.0302	CbGeAlD
Bromocriptine—HTR1D—blood vessel—melanoma	0.00219	0.0292	CbGeAlD
Bromocriptine—Disseminated intravascular coagulation—Docetaxel—melanoma	0.00217	0.00983	CcSEcCtD
Bromocriptine—Neurotoxicity—Docetaxel—melanoma	0.002	0.00906	CcSEcCtD
Bromocriptine—HTR2A—appendage—melanoma	0.00195	0.0261	CbGeAlD
Bromocriptine—Pericardial effusion—Docetaxel—melanoma	0.00189	0.00856	CcSEcCtD
Bromocriptine—HTR7—endothelium—melanoma	0.00189	0.0252	CbGeAlD
Bromocriptine—Paranoia—Carmustine—melanoma	0.00177	0.00802	CcSEcCtD
Bromocriptine—Pulmonary fibrosis—Docetaxel—melanoma	0.00176	0.00799	CcSEcCtD
Bromocriptine—HTR7—blood vessel—melanoma	0.00174	0.0233	CbGeAlD
Bromocriptine—Burning sensation—Carmustine—melanoma	0.00174	0.00787	CcSEcCtD
Bromocriptine—HTR7—neck—melanoma	0.00125	0.0166	CbGeAlD
Bromocriptine—HTR2A—endothelium—melanoma	0.00118	0.0157	CbGeAlD
Bromocriptine—DRD3—head—melanoma	0.00118	0.0157	CbGeAlD
Bromocriptine—Urinary incontinence—Carmustine—melanoma	0.00117	0.00528	CcSEcCtD
Bromocriptine—HTR1D—eye—melanoma	0.00116	0.0155	CbGeAlD
Bromocriptine—HTR6—head—melanoma	0.00113	0.0151	CbGeAlD
Bromocriptine—Oedema peripheral—Vemurafenib—melanoma	0.00113	0.00511	CcSEcCtD
Bromocriptine—Urinary incontinence—Temozolomide—melanoma	0.00113	0.0051	CcSEcCtD
Bromocriptine—Connective tissue disorder—Vemurafenib—melanoma	0.00113	0.0051	CcSEcCtD
Bromocriptine—Burning sensation—Docetaxel—melanoma	0.00112	0.00506	CcSEcCtD
Bromocriptine—DRD5—head—melanoma	0.0011	0.0147	CbGeAlD
Bromocriptine—HTR2A—blood vessel—melanoma	0.00109	0.0145	CbGeAlD
Bromocriptine—Eye disorder—Vemurafenib—melanoma	0.00107	0.00485	CcSEcCtD
Bromocriptine—Cardiac disorder—Vemurafenib—melanoma	0.00106	0.00482	CcSEcCtD
Bromocriptine—Dermatitis atopic—Docetaxel—melanoma	0.00105	0.00475	CcSEcCtD
Bromocriptine—Angiopathy—Vemurafenib—melanoma	0.00104	0.00471	CcSEcCtD
Bromocriptine—Mediastinal disorder—Vemurafenib—melanoma	0.00103	0.00468	CcSEcCtD
Bromocriptine—Cerebrovascular accident—Bleomycin—melanoma	0.00103	0.00464	CcSEcCtD
Bromocriptine—Pleural effusion—Docetaxel—melanoma	0.00101	0.00459	CcSEcCtD
Bromocriptine—Alopecia—Vemurafenib—melanoma	0.00101	0.00459	CcSEcCtD
Bromocriptine—Diabetes mellitus—Carmustine—melanoma	0.00101	0.00456	CcSEcCtD
Bromocriptine—Dysgeusia—Vemurafenib—melanoma	0.000978	0.00442	CcSEcCtD
Bromocriptine—Rhinorrhoea—Docetaxel—melanoma	0.000958	0.00434	CcSEcCtD
Bromocriptine—Lethargy—Dactinomycin—melanoma	0.000956	0.00433	CcSEcCtD
Bromocriptine—HTR2B—skin of body—melanoma	0.000942	0.0126	CbGeAlD
Bromocriptine—Nasal congestion—Temozolomide—melanoma	0.00093	0.00421	CcSEcCtD
Bromocriptine—ADRA1B—head—melanoma	0.000904	0.0121	CbGeAlD
Bromocriptine—ADRA1D—head—melanoma	0.000884	0.0118	CbGeAlD
Bromocriptine—Gastrointestinal haemorrhage—Carmustine—melanoma	0.000877	0.00397	CcSEcCtD
Bromocriptine—Diplopia—Carmustine—melanoma	0.000877	0.00397	CcSEcCtD
Bromocriptine—DRD2—eye—melanoma	0.000877	0.0117	CbGeAlD
Bromocriptine—DRD2—retina—melanoma	0.000869	0.0116	CbGeAlD
Bromocriptine—Diplopia—Temozolomide—melanoma	0.000847	0.00383	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.000844	0.00382	CcSEcCtD
Bromocriptine—DRD1—head—melanoma	0.000842	0.0112	CbGeAlD
Bromocriptine—Ataxia—Carmustine—melanoma	0.000824	0.00373	CcSEcCtD
Bromocriptine—Dysphagia—Dactinomycin—melanoma	0.00081	0.00366	CcSEcCtD
Bromocriptine—Infection—Vemurafenib—melanoma	0.00081	0.00366	CcSEcCtD
Bromocriptine—Nervous system disorder—Vemurafenib—melanoma	0.000799	0.00362	CcSEcCtD
Bromocriptine—Ataxia—Temozolomide—melanoma	0.000797	0.00361	CcSEcCtD
Bromocriptine—Skin disorder—Vemurafenib—melanoma	0.000791	0.00358	CcSEcCtD
Bromocriptine—HTR2A—neck—melanoma	0.000777	0.0104	CbGeAlD
Bromocriptine—Acute coronary syndrome—Bleomycin—melanoma	0.000763	0.00345	CcSEcCtD
Bromocriptine—Hypotension—Vemurafenib—melanoma	0.000761	0.00345	CcSEcCtD
Bromocriptine—Myocardial infarction—Bleomycin—melanoma	0.000759	0.00343	CcSEcCtD
Bromocriptine—Dysphagia—Carmustine—melanoma	0.000758	0.00343	CcSEcCtD
Bromocriptine—Dysphagia—Temozolomide—melanoma	0.000732	0.00331	CcSEcCtD
Bromocriptine—ABCB1—blood vessel—melanoma	0.000712	0.00951	CbGeAlD
Bromocriptine—Decreased appetite—Vemurafenib—melanoma	0.000708	0.00321	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Vemurafenib—melanoma	0.000703	0.00318	CcSEcCtD
Bromocriptine—Fatigue—Vemurafenib—melanoma	0.000703	0.00318	CcSEcCtD
Bromocriptine—Constipation—Vemurafenib—melanoma	0.000697	0.00315	CcSEcCtD
Bromocriptine—Lightheadedness—Docetaxel—melanoma	0.000695	0.00314	CcSEcCtD
Bromocriptine—Hypoaesthesia—Bleomycin—melanoma	0.000691	0.00313	CcSEcCtD
Bromocriptine—HTR1B—head—melanoma	0.000682	0.00911	CbGeAlD
Bromocriptine—Pollakiuria—Temozolomide—melanoma	0.000676	0.00306	CcSEcCtD
Bromocriptine—ADRA2C—mammalian vulva—melanoma	0.000676	0.00903	CbGeAlD
Bromocriptine—HTR1D—head—melanoma	0.000661	0.00882	CbGeAlD
Bromocriptine—HTR2C—head—melanoma	0.000654	0.00874	CbGeAlD
Bromocriptine—Body temperature increased—Vemurafenib—melanoma	0.000644	0.00291	CcSEcCtD
Bromocriptine—ADRB1—head—melanoma	0.000642	0.00857	CbGeAlD
Bromocriptine—Cardiac failure congestive—Docetaxel—melanoma	0.000621	0.00281	CcSEcCtD
Bromocriptine—HTR2B—head—melanoma	0.000615	0.00821	CbGeAlD
Bromocriptine—Alopecia—Bleomycin—melanoma	0.000614	0.00278	CcSEcCtD
Bromocriptine—Sinusitis—Temozolomide—melanoma	0.000613	0.00277	CcSEcCtD
Bromocriptine—Hypoaesthesia—Carmustine—melanoma	0.000604	0.00273	CcSEcCtD
Bromocriptine—Hallucination—Carmustine—melanoma	0.000604	0.00273	CcSEcCtD
Bromocriptine—Oedema peripheral—Carmustine—melanoma	0.000598	0.0027	CcSEcCtD
Bromocriptine—Connective tissue disorder—Carmustine—melanoma	0.000596	0.0027	CcSEcCtD
Bromocriptine—Visual disturbance—Docetaxel—melanoma	0.000595	0.00269	CcSEcCtD
Bromocriptine—Asthenia—Vemurafenib—melanoma	0.000585	0.00265	CcSEcCtD
Bromocriptine—Visual impairment—Carmustine—melanoma	0.000585	0.00265	CcSEcCtD
Bromocriptine—Hallucination—Temozolomide—melanoma	0.000583	0.00264	CcSEcCtD
Bromocriptine—Hypoaesthesia—Temozolomide—melanoma	0.000583	0.00264	CcSEcCtD
Bromocriptine—HTR2A—eye—melanoma	0.000578	0.00772	CbGeAlD
Bromocriptine—Oedema peripheral—Temozolomide—melanoma	0.000577	0.00261	CcSEcCtD
Bromocriptine—Connective tissue disorder—Temozolomide—melanoma	0.000576	0.00261	CcSEcCtD
Bromocriptine—Lethargy—Docetaxel—melanoma	0.000575	0.0026	CcSEcCtD
Bromocriptine—HTR2A—retina—melanoma	0.000573	0.00765	CbGeAlD
Bromocriptine—Alopecia—Dactinomycin—melanoma	0.000573	0.00259	CcSEcCtD
Bromocriptine—Eye disorder—Carmustine—melanoma	0.000567	0.00257	CcSEcCtD
Bromocriptine—Visual impairment—Temozolomide—melanoma	0.000565	0.00256	CcSEcCtD
Bromocriptine—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.000563	0.00255	CcSEcCtD
Bromocriptine—Diarrhoea—Vemurafenib—melanoma	0.000558	0.00252	CcSEcCtD
Bromocriptine—HTR1A—head—melanoma	0.000551	0.00735	CbGeAlD
Bromocriptine—Eye disorder—Temozolomide—melanoma	0.000548	0.00248	CcSEcCtD
Bromocriptine—Tinnitus—Temozolomide—melanoma	0.000547	0.00247	CcSEcCtD
Bromocriptine—Cardiac disorder—Temozolomide—melanoma	0.000544	0.00246	CcSEcCtD
Bromocriptine—Arrhythmia—Carmustine—melanoma	0.000542	0.00245	CcSEcCtD
Bromocriptine—ADRA2A—mammalian vulva—melanoma	0.00054	0.0072	CbGeAlD
Bromocriptine—Dizziness—Vemurafenib—melanoma	0.000539	0.00244	CcSEcCtD
Bromocriptine—Alopecia—Carmustine—melanoma	0.000536	0.00243	CcSEcCtD
Bromocriptine—Angiopathy—Temozolomide—melanoma	0.000532	0.00241	CcSEcCtD
Bromocriptine—Mental disorder—Carmustine—melanoma	0.000531	0.0024	CcSEcCtD
Bromocriptine—Ataxia—Docetaxel—melanoma	0.00053	0.0024	CcSEcCtD
Bromocriptine—Mediastinal disorder—Temozolomide—melanoma	0.000528	0.00239	CcSEcCtD
Bromocriptine—HTR7—head—melanoma	0.000526	0.00703	CbGeAlD
Bromocriptine—Vomiting—Vemurafenib—melanoma	0.000518	0.00234	CcSEcCtD
Bromocriptine—Alopecia—Temozolomide—melanoma	0.000518	0.00234	CcSEcCtD
Bromocriptine—Abdominal pain upper—Docetaxel—melanoma	0.000515	0.00233	CcSEcCtD
Bromocriptine—Orthostatic hypotension—Docetaxel—melanoma	0.000515	0.00233	CcSEcCtD
Bromocriptine—Rash—Vemurafenib—melanoma	0.000514	0.00232	CcSEcCtD
Bromocriptine—Mental disorder—Temozolomide—melanoma	0.000514	0.00232	CcSEcCtD
Bromocriptine—Dermatitis—Vemurafenib—melanoma	0.000513	0.00232	CcSEcCtD
Bromocriptine—Headache—Vemurafenib—melanoma	0.00051	0.00231	CcSEcCtD
Bromocriptine—ADRA1A—head—melanoma	0.000508	0.00678	CbGeAlD
Bromocriptine—Cramp muscle—Docetaxel—melanoma	0.000507	0.0023	CcSEcCtD
Bromocriptine—Nasopharyngitis—Docetaxel—melanoma	0.000504	0.00228	CcSEcCtD
Bromocriptine—Dysgeusia—Temozolomide—melanoma	0.0005	0.00226	CcSEcCtD
Bromocriptine—Confusional state—Bleomycin—melanoma	0.000498	0.00225	CcSEcCtD
Bromocriptine—DRD2—head—melanoma	0.000498	0.00664	CbGeAlD
Bromocriptine—Vision blurred—Carmustine—melanoma	0.000498	0.00225	CcSEcCtD
Bromocriptine—Oedema—Bleomycin—melanoma	0.000494	0.00223	CcSEcCtD
Bromocriptine—Infection—Bleomycin—melanoma	0.00049	0.00222	CcSEcCtD
Bromocriptine—Dysphagia—Docetaxel—melanoma	0.000487	0.0022	CcSEcCtD
Bromocriptine—Agitation—Carmustine—melanoma	0.000485	0.0022	CcSEcCtD
Bromocriptine—Nausea—Vemurafenib—melanoma	0.000484	0.00219	CcSEcCtD
Bromocriptine—ADRA2C—head—melanoma	0.000484	0.00646	CbGeAlD
Bromocriptine—Vision blurred—Temozolomide—melanoma	0.000481	0.00218	CcSEcCtD
Bromocriptine—Anorexia—Bleomycin—melanoma	0.000471	0.00213	CcSEcCtD
Bromocriptine—Agitation—Temozolomide—melanoma	0.000469	0.00212	CcSEcCtD
Bromocriptine—Hypotension—Bleomycin—melanoma	0.000461	0.00209	CcSEcCtD
Bromocriptine—Oedema—Dactinomycin—melanoma	0.00046	0.00208	CcSEcCtD
Bromocriptine—Vertigo—Temozolomide—melanoma	0.000458	0.00207	CcSEcCtD
Bromocriptine—Convulsion—Carmustine—melanoma	0.000457	0.00207	CcSEcCtD
Bromocriptine—Infection—Dactinomycin—melanoma	0.000457	0.00207	CcSEcCtD
Bromocriptine—Hypertension—Carmustine—melanoma	0.000456	0.00206	CcSEcCtD
Bromocriptine—Anxiety—Carmustine—melanoma	0.000448	0.00203	CcSEcCtD
Bromocriptine—Paraesthesia—Bleomycin—melanoma	0.000443	0.00201	CcSEcCtD
Bromocriptine—Convulsion—Temozolomide—melanoma	0.000442	0.002	CcSEcCtD
Bromocriptine—Hypertension—Temozolomide—melanoma	0.000441	0.00199	CcSEcCtD
Bromocriptine—Dyspnoea—Bleomycin—melanoma	0.00044	0.00199	CcSEcCtD
Bromocriptine—Anorexia—Dactinomycin—melanoma	0.000439	0.00199	CcSEcCtD
Bromocriptine—Confusional state—Carmustine—melanoma	0.000435	0.00197	CcSEcCtD
Bromocriptine—Anxiety—Temozolomide—melanoma	0.000433	0.00196	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000431	0.00195	CcSEcCtD
Bromocriptine—Oedema—Carmustine—melanoma	0.000431	0.00195	CcSEcCtD
Bromocriptine—HTR2B—lymph node—melanoma	0.00043	0.00575	CbGeAlD
Bromocriptine—Decreased appetite—Bleomycin—melanoma	0.000429	0.00194	CcSEcCtD
Bromocriptine—Infection—Carmustine—melanoma	0.000428	0.00194	CcSEcCtD
Bromocriptine—Acute coronary syndrome—Docetaxel—melanoma	0.000428	0.00194	CcSEcCtD
Bromocriptine—Myocardial infarction—Docetaxel—melanoma	0.000426	0.00193	CcSEcCtD
Bromocriptine—Dry mouth—Temozolomide—melanoma	0.000425	0.00192	CcSEcCtD
Bromocriptine—Tachycardia—Carmustine—melanoma	0.000421	0.0019	CcSEcCtD
Bromocriptine—Confusional state—Temozolomide—melanoma	0.00042	0.0019	CcSEcCtD
Bromocriptine—Oedema—Temozolomide—melanoma	0.000416	0.00188	CcSEcCtD
Bromocriptine—Infection—Temozolomide—melanoma	0.000414	0.00187	CcSEcCtD
Bromocriptine—Anorexia—Carmustine—melanoma	0.000411	0.00186	CcSEcCtD
Bromocriptine—Nervous system disorder—Temozolomide—melanoma	0.000408	0.00185	CcSEcCtD
Bromocriptine—Feeling abnormal—Bleomycin—melanoma	0.000407	0.00184	CcSEcCtD
Bromocriptine—Skin disorder—Temozolomide—melanoma	0.000404	0.00183	CcSEcCtD
Bromocriptine—Hypotension—Carmustine—melanoma	0.000403	0.00182	CcSEcCtD
Bromocriptine—Decreased appetite—Dactinomycin—melanoma	0.0004	0.00181	CcSEcCtD
Bromocriptine—Dihydroergotamine—ABCB1—melanoma	0.0004	0.411	CrCbGaD
Bromocriptine—Fatigue—Dactinomycin—melanoma	0.000397	0.0018	CcSEcCtD
Bromocriptine—Anorexia—Temozolomide—melanoma	0.000397	0.0018	CcSEcCtD
Bromocriptine—Urticaria—Bleomycin—melanoma	0.000392	0.00177	CcSEcCtD
Bromocriptine—Rhinitis—Docetaxel—melanoma	0.000391	0.00177	CcSEcCtD
Bromocriptine—Body temperature increased—Bleomycin—melanoma	0.00039	0.00177	CcSEcCtD
Bromocriptine—Insomnia—Carmustine—melanoma	0.00039	0.00176	CcSEcCtD
Bromocriptine—Hypoaesthesia—Docetaxel—melanoma	0.000388	0.00176	CcSEcCtD
Bromocriptine—Paraesthesia—Carmustine—melanoma	0.000387	0.00175	CcSEcCtD
Bromocriptine—ADRA2A—head—melanoma	0.000386	0.00515	CbGeAlD
Bromocriptine—Dyspnoea—Carmustine—melanoma	0.000384	0.00174	CcSEcCtD
Bromocriptine—Oedema peripheral—Docetaxel—melanoma	0.000384	0.00174	CcSEcCtD
Bromocriptine—Somnolence—Carmustine—melanoma	0.000383	0.00173	CcSEcCtD
Bromocriptine—Connective tissue disorder—Docetaxel—melanoma	0.000383	0.00173	CcSEcCtD
Bromocriptine—Feeling abnormal—Dactinomycin—melanoma	0.000379	0.00172	CcSEcCtD
Bromocriptine—Insomnia—Temozolomide—melanoma	0.000377	0.0017	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Dactinomycin—melanoma	0.000376	0.0017	CcSEcCtD
Bromocriptine—Visual impairment—Docetaxel—melanoma	0.000376	0.0017	CcSEcCtD
Bromocriptine—ABCB1—retina—melanoma	0.000375	0.00501	CbGeAlD
Bromocriptine—Decreased appetite—Carmustine—melanoma	0.000375	0.0017	CcSEcCtD
Bromocriptine—Paraesthesia—Temozolomide—melanoma	0.000374	0.00169	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Carmustine—melanoma	0.000372	0.00168	CcSEcCtD
Bromocriptine—Dyspnoea—Temozolomide—melanoma	0.000371	0.00168	CcSEcCtD
Bromocriptine—Somnolence—Temozolomide—melanoma	0.00037	0.00168	CcSEcCtD
Bromocriptine—Constipation—Carmustine—melanoma	0.000369	0.00167	CcSEcCtD
Bromocriptine—Dyspepsia—Temozolomide—melanoma	0.000367	0.00166	CcSEcCtD
Bromocriptine—Ergonovine—ABCB1—melanoma	0.000366	0.376	CrCbGaD
Bromocriptine—Eye disorder—Docetaxel—melanoma	0.000364	0.00165	CcSEcCtD
Bromocriptine—Abdominal pain—Dactinomycin—melanoma	0.000364	0.00165	CcSEcCtD
Bromocriptine—Body temperature increased—Dactinomycin—melanoma	0.000364	0.00165	CcSEcCtD
Bromocriptine—Decreased appetite—Temozolomide—melanoma	0.000362	0.00164	CcSEcCtD
Bromocriptine—Cardiac disorder—Docetaxel—melanoma	0.000362	0.00164	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Temozolomide—melanoma	0.00036	0.00163	CcSEcCtD
Bromocriptine—Fatigue—Temozolomide—melanoma	0.000359	0.00162	CcSEcCtD
Bromocriptine—Constipation—Temozolomide—melanoma	0.000356	0.00161	CcSEcCtD
Bromocriptine—Feeling abnormal—Carmustine—melanoma	0.000355	0.00161	CcSEcCtD
Bromocriptine—Asthenia—Bleomycin—melanoma	0.000354	0.0016	CcSEcCtD
Bromocriptine—Angiopathy—Docetaxel—melanoma	0.000354	0.0016	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Carmustine—melanoma	0.000352	0.00159	CcSEcCtD
Bromocriptine—Mediastinal disorder—Docetaxel—melanoma	0.000351	0.00159	CcSEcCtD
Bromocriptine—Arrhythmia—Docetaxel—melanoma	0.000348	0.00158	CcSEcCtD
Bromocriptine—Alopecia—Docetaxel—melanoma	0.000344	0.00156	CcSEcCtD
Bromocriptine—Feeling abnormal—Temozolomide—melanoma	0.000343	0.00155	CcSEcCtD
Bromocriptine—Mental disorder—Docetaxel—melanoma	0.000342	0.00155	CcSEcCtD
Bromocriptine—Body temperature increased—Carmustine—melanoma	0.000341	0.00154	CcSEcCtD
Bromocriptine—Abdominal pain—Carmustine—melanoma	0.000341	0.00154	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Temozolomide—melanoma	0.000341	0.00154	CcSEcCtD
Bromocriptine—ADRA2C—lymph node—melanoma	0.000339	0.00452	CbGeAlD
Bromocriptine—Dysgeusia—Docetaxel—melanoma	0.000332	0.0015	CcSEcCtD
Bromocriptine—Urticaria—Temozolomide—melanoma	0.000331	0.0015	CcSEcCtD
Bromocriptine—Asthenia—Dactinomycin—melanoma	0.00033	0.00149	CcSEcCtD
Bromocriptine—Body temperature increased—Temozolomide—melanoma	0.000329	0.00149	CcSEcCtD
Bromocriptine—Abdominal pain—Temozolomide—melanoma	0.000329	0.00149	CcSEcCtD
Bromocriptine—HTR2A—head—melanoma	0.000328	0.00438	CbGeAlD
Bromocriptine—Muscle spasms—Docetaxel—melanoma	0.000326	0.00148	CcSEcCtD
Bromocriptine—Diarrhoea—Dactinomycin—melanoma	0.000315	0.00143	CcSEcCtD
Bromocriptine—Vomiting—Bleomycin—melanoma	0.000314	0.00142	CcSEcCtD
Bromocriptine—Rash—Bleomycin—melanoma	0.000311	0.00141	CcSEcCtD
Bromocriptine—Dermatitis—Bleomycin—melanoma	0.000311	0.00141	CcSEcCtD
Bromocriptine—Asthenia—Carmustine—melanoma	0.000309	0.0014	CcSEcCtD
Bromocriptine—Syncope—Docetaxel—melanoma	0.000304	0.00138	CcSEcCtD
Bromocriptine—ABCB1—mammalian vulva—melanoma	0.000301	0.00401	CbGeAlD
Bromocriptine—Asthenia—Temozolomide—melanoma	0.000299	0.00135	CcSEcCtD
Bromocriptine—Loss of consciousness—Docetaxel—melanoma	0.000298	0.00135	CcSEcCtD
Bromocriptine—Diarrhoea—Carmustine—melanoma	0.000295	0.00133	CcSEcCtD
Bromocriptine—Convulsion—Docetaxel—melanoma	0.000294	0.00133	CcSEcCtD
Bromocriptine—Nausea—Bleomycin—melanoma	0.000293	0.00133	CcSEcCtD
Bromocriptine—Hypertension—Docetaxel—melanoma	0.000293	0.00133	CcSEcCtD
Bromocriptine—Vomiting—Dactinomycin—melanoma	0.000293	0.00132	CcSEcCtD
Bromocriptine—Rash—Dactinomycin—melanoma	0.00029	0.00131	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000287	0.0013	CcSEcCtD
Bromocriptine—Dizziness—Carmustine—melanoma	0.000285	0.00129	CcSEcCtD
Bromocriptine—Diarrhoea—Temozolomide—melanoma	0.000285	0.00129	CcSEcCtD
Bromocriptine—Dry mouth—Docetaxel—melanoma	0.000283	0.00128	CcSEcCtD
Bromocriptine—Confusional state—Docetaxel—melanoma	0.000279	0.00126	CcSEcCtD
Bromocriptine—Oedema—Docetaxel—melanoma	0.000277	0.00125	CcSEcCtD
Bromocriptine—Dizziness—Temozolomide—melanoma	0.000275	0.00125	CcSEcCtD
Bromocriptine—Infection—Docetaxel—melanoma	0.000275	0.00124	CcSEcCtD
Bromocriptine—Vomiting—Carmustine—melanoma	0.000274	0.00124	CcSEcCtD
Bromocriptine—Nausea—Dactinomycin—melanoma	0.000273	0.00124	CcSEcCtD
Bromocriptine—Shock—Docetaxel—melanoma	0.000272	0.00123	CcSEcCtD
Bromocriptine—Rash—Carmustine—melanoma	0.000272	0.00123	CcSEcCtD
Bromocriptine—Nervous system disorder—Docetaxel—melanoma	0.000272	0.00123	CcSEcCtD
Bromocriptine—Dermatitis—Carmustine—melanoma	0.000271	0.00123	CcSEcCtD
Bromocriptine—ADRA2A—lymph node—melanoma	0.00027	0.00361	CbGeAlD
Bromocriptine—Tachycardia—Docetaxel—melanoma	0.00027	0.00122	CcSEcCtD
Bromocriptine—Headache—Carmustine—melanoma	0.00027	0.00122	CcSEcCtD
Bromocriptine—Skin disorder—Docetaxel—melanoma	0.000269	0.00122	CcSEcCtD
Bromocriptine—Vomiting—Temozolomide—melanoma	0.000265	0.0012	CcSEcCtD
Bromocriptine—Anorexia—Docetaxel—melanoma	0.000264	0.00119	CcSEcCtD
Bromocriptine—Rash—Temozolomide—melanoma	0.000263	0.00119	CcSEcCtD
Bromocriptine—Dermatitis—Temozolomide—melanoma	0.000262	0.00119	CcSEcCtD
Bromocriptine—Headache—Temozolomide—melanoma	0.000261	0.00118	CcSEcCtD
Bromocriptine—Hypotension—Docetaxel—melanoma	0.000259	0.00117	CcSEcCtD
Bromocriptine—Nausea—Carmustine—melanoma	0.000256	0.00116	CcSEcCtD
Bromocriptine—Insomnia—Docetaxel—melanoma	0.00025	0.00113	CcSEcCtD
Bromocriptine—Paraesthesia—Docetaxel—melanoma	0.000249	0.00113	CcSEcCtD
Bromocriptine—Nausea—Temozolomide—melanoma	0.000247	0.00112	CcSEcCtD
Bromocriptine—Dyspnoea—Docetaxel—melanoma	0.000247	0.00112	CcSEcCtD
Bromocriptine—Somnolence—Docetaxel—melanoma	0.000246	0.00111	CcSEcCtD
Bromocriptine—Dyspepsia—Docetaxel—melanoma	0.000244	0.0011	CcSEcCtD
Bromocriptine—Decreased appetite—Docetaxel—melanoma	0.000241	0.00109	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Docetaxel—melanoma	0.000239	0.00108	CcSEcCtD
Bromocriptine—Fatigue—Docetaxel—melanoma	0.000239	0.00108	CcSEcCtD
Bromocriptine—Constipation—Docetaxel—melanoma	0.000237	0.00107	CcSEcCtD
Bromocriptine—Feeling abnormal—Docetaxel—melanoma	0.000228	0.00103	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Docetaxel—melanoma	0.000226	0.00102	CcSEcCtD
Bromocriptine—Body temperature increased—Docetaxel—melanoma	0.000219	0.000991	CcSEcCtD
Bromocriptine—Abdominal pain—Docetaxel—melanoma	0.000219	0.000991	CcSEcCtD
Bromocriptine—ABCB1—head—melanoma	0.000215	0.00287	CbGeAlD
Bromocriptine—Ergotamine—ABCB1—melanoma	0.000206	0.212	CrCbGaD
Bromocriptine—Asthenia—Docetaxel—melanoma	0.000199	0.000899	CcSEcCtD
Bromocriptine—Diarrhoea—Docetaxel—melanoma	0.000189	0.000857	CcSEcCtD
Bromocriptine—Dizziness—Docetaxel—melanoma	0.000183	0.000829	CcSEcCtD
Bromocriptine—Vomiting—Docetaxel—melanoma	0.000176	0.000797	CcSEcCtD
Bromocriptine—Rash—Docetaxel—melanoma	0.000175	0.00079	CcSEcCtD
Bromocriptine—Dermatitis—Docetaxel—melanoma	0.000174	0.000789	CcSEcCtD
Bromocriptine—Headache—Docetaxel—melanoma	0.000173	0.000785	CcSEcCtD
Bromocriptine—Nausea—Docetaxel—melanoma	0.000164	0.000744	CcSEcCtD
Bromocriptine—ABCB1—lymph node—melanoma	0.000151	0.00201	CbGeAlD
Bromocriptine—HTR2A—GPCR downstream signaling—AKT1—melanoma	4.33e-06	1.93e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—STAT3—melanoma	4.32e-06	1.93e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—PIK3CA—melanoma	4.32e-06	1.93e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—NRAS—melanoma	4.31e-06	1.92e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—TP53—melanoma	4.3e-06	1.92e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—ERBB2—melanoma	4.3e-06	1.92e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—TP53—melanoma	4.3e-06	1.92e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CASP3—melanoma	4.29e-06	1.91e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CDKN1B—melanoma	4.28e-06	1.91e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IL2—melanoma	4.28e-06	1.91e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—TP53—melanoma	4.27e-06	1.9e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—IL6—melanoma	4.26e-06	1.9e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—PIK3CA—melanoma	4.25e-06	1.9e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CCND1—melanoma	4.24e-06	1.89e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—PIK3CB—melanoma	4.24e-06	1.89e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—AKT1—melanoma	4.24e-06	1.89e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—VEGFA—melanoma	4.21e-06	1.88e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CTNNB1—melanoma	4.2e-06	1.87e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CASP3—melanoma	4.2e-06	1.87e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IL2—melanoma	4.19e-06	1.87e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—VEGFA—melanoma	4.19e-06	1.87e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—TP53—melanoma	4.18e-06	1.86e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CCND1—melanoma	4.17e-06	1.86e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—IL6—melanoma	4.17e-06	1.86e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—STAT3—melanoma	4.17e-06	1.86e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—MAPK3—melanoma	4.17e-06	1.86e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—KRAS—melanoma	4.16e-06	1.86e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—NRAS—melanoma	4.16e-06	1.86e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—STAT3—melanoma	4.15e-06	1.85e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—NRAS—melanoma	4.14e-06	1.85e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CTNNB1—melanoma	4.13e-06	1.84e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—MAPK3—melanoma	4.13e-06	1.84e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MMP9—melanoma	4.12e-06	1.84e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—HRAS—melanoma	4.11e-06	1.83e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—TP53—melanoma	4.11e-06	1.83e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—KRAS—melanoma	4.11e-06	1.83e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—KRAS—melanoma	4.11e-06	1.83e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—HRAS—melanoma	4.11e-06	1.83e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CDKN1A—melanoma	4.1e-06	1.83e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—PTEN—melanoma	4.09e-06	1.83e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CCND1—melanoma	4.09e-06	1.82e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—HRAS—melanoma	4.08e-06	1.82e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CXCL8—melanoma	4.08e-06	1.82e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—VEGFA—melanoma	4.08e-06	1.82e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—NFKB1—melanoma	4.08e-06	1.82e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—PIK3CA—melanoma	4.06e-06	1.81e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MMP9—melanoma	4.05e-06	1.81e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—MYC—melanoma	4.05e-06	1.81e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—HRAS—melanoma	4.05e-06	1.81e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CTNNB1—melanoma	4.05e-06	1.81e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CDKN1A—melanoma	4.04e-06	1.8e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—STAT3—melanoma	4.04e-06	1.8e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—PTEN—melanoma	4.03e-06	1.8e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—NRAS—melanoma	4.03e-06	1.8e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PIK3CD—melanoma	4.02e-06	1.8e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—MYC—melanoma	4.02e-06	1.79e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—VEGFA—melanoma	4.01e-06	1.79e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—NFKB1—melanoma	4.01e-06	1.79e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—HRAS—melanoma	4e-06	1.78e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—AKT1—melanoma	3.99e-06	1.78e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MAPK3—melanoma	3.99e-06	1.78e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CDKN1B—melanoma	3.98e-06	1.78e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—ALB—melanoma	3.97e-06	1.77e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—STAT3—melanoma	3.97e-06	1.77e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MMP9—melanoma	3.97e-06	1.77e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MAPK3—melanoma	3.96e-06	1.77e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—MAPK1—melanoma	3.96e-06	1.77e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—EGFR—melanoma	3.96e-06	1.77e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—NRAS—melanoma	3.96e-06	1.77e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CDKN1A—melanoma	3.95e-06	1.76e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—PTEN—melanoma	3.95e-06	1.76e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—AKT1—melanoma	3.94e-06	1.76e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—IL6—melanoma	3.94e-06	1.76e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—HRAS—melanoma	3.93e-06	1.75e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—IL6—melanoma	3.93e-06	1.75e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—AKT1—melanoma	3.93e-06	1.75e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—MAPK1—melanoma	3.93e-06	1.75e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—EGFR—melanoma	3.93e-06	1.75e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—NFKB1—melanoma	3.93e-06	1.75e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—TP53—melanoma	3.93e-06	1.75e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—ABCB1—melanoma	3.91e-06	1.75e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—IL6—melanoma	3.91e-06	1.74e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CASP3—melanoma	3.9e-06	1.74e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IL2—melanoma	3.9e-06	1.74e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—IL6—melanoma	3.88e-06	1.73e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MYC—melanoma	3.88e-06	1.73e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MAPK3—melanoma	3.86e-06	1.72e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MYC—melanoma	3.86e-06	1.72e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—AKT1—melanoma	3.85e-06	1.72e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.83e-06	1.71e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—PIK3CA—melanoma	3.83e-06	1.71e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—IL6—melanoma	3.82e-06	1.71e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—PIK3CA—melanoma	3.81e-06	1.7e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CCND1—melanoma	3.8e-06	1.69e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MAPK3—melanoma	3.8e-06	1.69e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MAPK1—melanoma	3.79e-06	1.69e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—EGFR—melanoma	3.79e-06	1.69e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—PIK3CA—melanoma	3.78e-06	1.68e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—PIK3CA—melanoma	3.78e-06	1.68e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MAPK1—melanoma	3.77e-06	1.68e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—EGFR—melanoma	3.77e-06	1.68e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—IL6—melanoma	3.76e-06	1.68e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CTNNB1—melanoma	3.76e-06	1.68e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—HRAS—melanoma	3.75e-06	1.67e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MYC—melanoma	3.75e-06	1.67e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—KRAS—melanoma	3.74e-06	1.67e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—KRAS—melanoma	3.71e-06	1.65e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—TP53—melanoma	3.7e-06	1.65e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—VEGFA—melanoma	3.7e-06	1.65e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MYC—melanoma	3.69e-06	1.65e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MMP9—melanoma	3.69e-06	1.64e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CDKN1A—melanoma	3.67e-06	1.64e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MAPK1—melanoma	3.67e-06	1.64e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—EGFR—melanoma	3.67e-06	1.64e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—PTEN—melanoma	3.67e-06	1.64e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—STAT3—melanoma	3.66e-06	1.63e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PIK3CG—melanoma	3.65e-06	1.63e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—NRAS—melanoma	3.65e-06	1.63e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—TP53—melanoma	3.65e-06	1.63e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—TP53—melanoma	3.65e-06	1.63e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—NFKB1—melanoma	3.65e-06	1.63e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—VEGFA—melanoma	3.64e-06	1.62e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—AKT1—melanoma	3.63e-06	1.62e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—AKT1—melanoma	3.63e-06	1.62e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MAPK1—melanoma	3.61e-06	1.61e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—EGFR—melanoma	3.61e-06	1.61e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—AKT1—melanoma	3.6e-06	1.61e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—STAT3—melanoma	3.6e-06	1.61e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PRKCA—melanoma	3.6e-06	1.61e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—NRAS—melanoma	3.59e-06	1.6e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—IL6—melanoma	3.59e-06	1.6e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—KRAS—melanoma	3.58e-06	1.6e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—AKT1—melanoma	3.58e-06	1.6e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—ERCC2—melanoma	3.57e-06	1.59e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—VEGFA—melanoma	3.56e-06	1.59e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—KRAS—melanoma	3.56e-06	1.59e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—HRAS—melanoma	3.54e-06	1.58e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—AKT1—melanoma	3.53e-06	1.57e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—STAT3—melanoma	3.53e-06	1.57e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PPARG—melanoma	3.53e-06	1.57e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—NRAS—melanoma	3.52e-06	1.57e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PIK3CB—melanoma	3.51e-06	1.56e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MAPK3—melanoma	3.5e-06	1.56e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—HRAS—melanoma	3.49e-06	1.56e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—HRAS—melanoma	3.49e-06	1.56e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PTGS2—melanoma	3.48e-06	1.55e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—AKT1—melanoma	3.47e-06	1.55e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—KRAS—melanoma	3.47e-06	1.55e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MAPK3—melanoma	3.44e-06	1.54e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—PIK3CA—melanoma	3.44e-06	1.53e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—KRAS—melanoma	3.41e-06	1.52e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—PIK3CA—melanoma	3.41e-06	1.52e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MYC—melanoma	3.4e-06	1.52e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—IL6—melanoma	3.39e-06	1.51e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MAPK3—melanoma	3.37e-06	1.5e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MYC—melanoma	3.35e-06	1.49e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—IL6—melanoma	3.34e-06	1.49e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—IL6—melanoma	3.34e-06	1.49e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MAPK1—melanoma	3.33e-06	1.48e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—EGFR—melanoma	3.33e-06	1.48e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—TP53—melanoma	3.33e-06	1.48e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—AKT1—melanoma	3.31e-06	1.48e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—VEGFA—melanoma	3.31e-06	1.48e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—TP53—melanoma	3.3e-06	1.47e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—PIK3CA—melanoma	3.29e-06	1.47e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MYC—melanoma	3.28e-06	1.46e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—STAT3—melanoma	3.28e-06	1.46e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MAPK1—melanoma	3.28e-06	1.46e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—EGFR—melanoma	3.28e-06	1.46e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—PIK3CA—melanoma	3.27e-06	1.46e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—NRAS—melanoma	3.27e-06	1.46e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PIK3CD—melanoma	3.21e-06	1.43e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MAPK1—melanoma	3.21e-06	1.43e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—EGFR—melanoma	3.21e-06	1.43e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—PIK3CA—melanoma	3.18e-06	1.42e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TP53—melanoma	3.18e-06	1.42e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—HRAS—melanoma	3.18e-06	1.42e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—ALB—melanoma	3.17e-06	1.41e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TP53—melanoma	3.17e-06	1.41e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—HRAS—melanoma	3.15e-06	1.41e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—KRAS—melanoma	3.14e-06	1.4e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—PIK3CA—melanoma	3.13e-06	1.4e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MAPK3—melanoma	3.13e-06	1.4e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—AKT1—melanoma	3.13e-06	1.39e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—AKT1—melanoma	3.11e-06	1.39e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—KRAS—melanoma	3.09e-06	1.38e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—PIK3CA—melanoma	3.09e-06	1.38e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—AKT1—melanoma	3.08e-06	1.38e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—AKT1—melanoma	3.08e-06	1.38e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TP53—melanoma	3.08e-06	1.37e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MYC—melanoma	3.05e-06	1.36e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—IL6—melanoma	3.05e-06	1.36e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—HRAS—melanoma	3.04e-06	1.36e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PTEN—melanoma	3.03e-06	1.35e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TP53—melanoma	3.03e-06	1.35e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—KRAS—melanoma	3.03e-06	1.35e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—HRAS—melanoma	3.03e-06	1.35e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—IL6—melanoma	3.02e-06	1.35e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MAPK1—melanoma	2.98e-06	1.33e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—EGFR—melanoma	2.98e-06	1.33e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—HRAS—melanoma	2.95e-06	1.31e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—IL6—melanoma	2.91e-06	1.3e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—HRAS—melanoma	2.9e-06	1.29e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—IL6—melanoma	2.9e-06	1.29e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—PIK3CA—melanoma	2.89e-06	1.29e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—PIK3CA—melanoma	2.84e-06	1.27e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PIK3CG—melanoma	2.82e-06	1.26e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—IL6—melanoma	2.82e-06	1.26e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—KRAS—melanoma	2.81e-06	1.26e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—AKT1—melanoma	2.81e-06	1.25e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PIK3CB—melanoma	2.8e-06	1.25e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TP53—melanoma	2.79e-06	1.25e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—AKT1—melanoma	2.78e-06	1.24e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—PIK3CA—melanoma	2.78e-06	1.24e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PTGS2—melanoma	2.77e-06	1.24e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—IL6—melanoma	2.77e-06	1.24e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TP53—melanoma	2.75e-06	1.23e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PPARG—melanoma	2.72e-06	1.21e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TP53—melanoma	2.69e-06	1.2e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—AKT1—melanoma	2.69e-06	1.2e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—AKT1—melanoma	2.67e-06	1.19e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—HRAS—melanoma	2.67e-06	1.19e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—HRAS—melanoma	2.63e-06	1.17e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—AKT1—melanoma	2.6e-06	1.16e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—PIK3CA—melanoma	2.59e-06	1.15e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—HRAS—melanoma	2.58e-06	1.15e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—AKT1—melanoma	2.56e-06	1.14e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IL6—melanoma	2.56e-06	1.14e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—AKT1—melanoma	2.53e-06	1.13e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IL6—melanoma	2.52e-06	1.12e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TP53—melanoma	2.5e-06	1.12e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PIK3CD—melanoma	2.48e-06	1.11e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IL6—melanoma	2.46e-06	1.1e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—ALB—melanoma	2.45e-06	1.09e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PTEN—melanoma	2.42e-06	1.08e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—HRAS—melanoma	2.39e-06	1.07e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—AKT1—melanoma	2.36e-06	1.05e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—AKT1—melanoma	2.32e-06	1.04e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IL6—melanoma	2.29e-06	1.02e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—AKT1—melanoma	2.27e-06	1.01e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PIK3CB—melanoma	2.16e-06	9.64e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PTGS2—melanoma	2.14e-06	9.55e-06	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PIK3CA—melanoma	2.14e-06	9.54e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—AKT1—melanoma	2.11e-06	9.42e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PTEN—melanoma	1.87e-06	8.33e-06	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—AKT1—melanoma	1.75e-06	7.79e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PIK3CA—melanoma	1.71e-06	7.62e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—AKT1—melanoma	1.39e-06	6.22e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PIK3CA—melanoma	1.32e-06	5.88e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—AKT1—melanoma	1.08e-06	4.8e-06	CbGpPWpGaD
